Immunolabelling of Brn3a, a cell-specific transcription factor, improved RGC quantification [20] and showed that STZ-diabetes significantly reduced RGCs by about 7% after 6 weeks and 15% after 12 weeks of hyperglycemia in rodents [21]. The gene discussed is POU4F1; the disease is Hyperglycemia.